Brief: BLIS Technologies Says Co's Oral Probiotic BLIS M18 Obtains GRAS Status
02/05/2018 07:43
May 2 (Reuters) - BLIS Technologies Ltd BLT.NZ :
* CO'S ORAL PROBIOTIC BLIS M18 OBTAINS GRAS STATUS ENABLING
THE
PROBIOTIC TO BE INCLUDED AS INGREDIENT IN FOOD PRODUCTS WITHIN
U.S.
Source text for Eikon: ID:nNZW8GZ8LH
Further company coverage: BLT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BLIS Technologies
See all newsBrief: Blis Technologies Says Strong 1Q27 Supports Growth Outlook
New Zealand's BLIS Technologies Q1 revenue rises on ingredient sales growth
Brief: BLIS Technologies Posts Q1 EBITDA Of NZD 1.1 million
New Zealand's BLIS Technologies advances on upbeat annual results
Brief: BLIS Technologies Says Co Suffered Minimal Economic Loss From Uncertainty Surrounding Middle East